These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

72 related articles for article (PubMed ID: 8296398)

  • 1. Effects of 'rogue' points on non-linear fitting.
    Barlow RB
    Trends Pharmacol Sci; 1993 Nov; 14(11):399-403. PubMed ID: 8296398
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antagonist inhibition curves and the measurement of dissociation constants.
    Barlow RB; Bond SM; Bream E; Macfarlane L; McQueen DS
    Br J Pharmacol; 1997 Jan; 120(1):13-8. PubMed ID: 9117087
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Developments of computer-based estimation of pA2 values and associated analysis.
    Stone M; Angus JA
    J Pharmacol Exp Ther; 1978 Dec; 207(3):705-18. PubMed ID: 731426
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Binding surface analysis: an intuitive yet quantitative method for the design and analysis of ligand binding studies.
    Rothman RB
    Alcohol Drug Res; 1985-1986; 6(5):309-25. PubMed ID: 3011024
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The influence of cooperativity on the determination of dissociation constants: examination of the Cheng-Prusoff equation, the Scatchard analysis, the Schild analysis and related power equations.
    Cheng HC
    Pharmacol Res; 2004 Jul; 50(1):21-40. PubMed ID: 15082026
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Kinetic and equilibrium studies of Ah receptor-ligand binding: use of [125I]2-iodo-7,8-dibromodibenzo-p-dioxin.
    Bradfield CA; Kende AS; Poland A
    Mol Pharmacol; 1988 Aug; 34(2):229-37. PubMed ID: 2842655
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tissue response as a functional discriminator of receptor heterogeneity: effects of mixed receptor populations on Schild regressions.
    Kenakin TP
    Mol Pharmacol; 1992 Apr; 41(4):699-707. PubMed ID: 1569922
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Computational tools for fitting the Hill equation to dose-response curves.
    Gadagkar SR; Call GB
    J Pharmacol Toxicol Methods; 2015; 71():68-76. PubMed ID: 25157754
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Improved curve fitting procedures to determine equilibrium binding constants.
    Stootman FH; Fisher DM; Rodger A; Aldrich-Wright JR
    Analyst; 2006 Oct; 131(10):1145-51. PubMed ID: 17003863
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A new method for estimation of agonist dissociation constants (KA): directly fitting the postinactivation concentration-response curve to a nested hyperbolic equation.
    James MK; Morgan PH; Leighton HJ
    J Pharmacol Exp Ther; 1989 Apr; 249(1):61-9. PubMed ID: 2540322
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Assessment of quality performance parameters for straight line calibration curves related to the spread of the abscissa values around their mean.
    De Beer JO; De Beer TR; Goeyens L
    Anal Chim Acta; 2007 Feb; 584(1):57-65. PubMed ID: 17386585
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The use of drug-receptor affinity measures in the differentiation of receptors.
    Tallarida RJ
    Fed Proc; 1982 May; 41(7):2323-7. PubMed ID: 6122613
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of models for analysis of radioligand binding data.
    Abramson SN; McGonigle P; Molinoff PB
    Mol Pharmacol; 1987 Jan; 31(1):103-11. PubMed ID: 3027522
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Estimation of the affinities of allosteric ligands using radioligand binding and pharmacological null methods.
    Ehlert FJ
    Mol Pharmacol; 1988 Feb; 33(2):187-94. PubMed ID: 2828914
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A mechanistic, predictive model of dose-response curves for cell cycle phase-specific and -nonspecific drugs.
    Gardner SN
    Cancer Res; 2000 Mar; 60(5):1417-25. PubMed ID: 10728708
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rational design of receptor partial agonists and possible mechanisms of receptor partial activation: a theory.
    Zhu BT
    J Theor Biol; 1996 Aug; 181(3):273-91. PubMed ID: 8869127
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Design and sample size for evaluating combinations of drugs of linear and loglinear dose-response curves.
    Fang HB; Tian GL; Li W; Tan M
    J Biopharm Stat; 2009 Jul; 19(4):625-40. PubMed ID: 20183430
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacodynamic models: parameterizing the hill equation, Michaelis-Menten, the logistic curve, and relationships among these models.
    Reeve R; Turner JR
    J Biopharm Stat; 2013 May; 23(3):648-61. PubMed ID: 23611201
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Round-off error, blind faith, and the powers that be: a caution on numerical error in coefficients for polynomial curves fit to psychophysical data.
    Samar VJ; De Filippo CL
    J Outcome Meas; 1998; 2(2):159-67. PubMed ID: 9661737
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Application of the four-parameter logistic model to bioassay: comparison with slope ratio and parallel line models.
    Vølund A
    Biometrics; 1978 Sep; 34(3):357-65. PubMed ID: 719119
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.